Higher versus lower blood pressure targets for vasopressor therapy in shock: A multicentre pilot randomized controlled trial.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Purpose In shock, hypotension may contribute to inadequate oxygen delivery, organ failure and death. We conducted the Optimal Vasopressor Titration (OVATION) pilot trial to inform the design of a larger trial examining the effect of lower versus higher mean arterial pressure (MAP) targets for vasopressor therapy in shock. Methods We randomly assigned critically ill patients who were presumed to suffer from vasodilatory shock regardless of admission diagnosis to a lower (60-65 mmHg) versus a higher (75-80 mmHg) MAP target. The primary objective was to measure the separation in MAP between groups. We also recorded days with protocol deviations, enrolment rate, cardiac arrhythmias and mortality for prespecified subgroups. Results A total of 118 patients were enrolled from 11 centres (2.3 patients/site/month of screening). The between-group separation in MAP was 9 mmHg (95% CI 7-11). In the lower and higher MAP groups, we observed deviations on 12 versus 8% of all days on vasopressors (p = 0.059). Risks of cardiac arrhythmias (20 versus 36%, p = 0.07) and hospital mortality (30 versus 33%, p = 0.84) were not different between lower and higher MAP arms. Among patients aged 75 years or older, a lower MAP target was associated with reduced hospital mortality (13 versus 60%, p = 0.03) but not in younger patients. Conclusions This pilot study supports the feasibility of a large trial comparing lower versus higher MAP targets for shock. Further research may help delineate the reasons f…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent RCT, monitored to ensure protocol and MAP target compliance, compared a “permissive hypotension” (MAP 60–65 mm Hg) group with a “usual care” group that received vasopressors and MAP targets set by the treating physician in patients aged 65 years and older with septic shock [82, 83]. The intervention group in this study achieved a mean MAP of 66.7 mm Hg, compared with 72.6 mm Hg in the”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [82]
In the citing paper
“Among 2463 analysed patients, there was significantly less exposure to vasopressors in the intervention group, measured by duration of vasopressor infusion and total vasopressor doses expressed in norepinephrine equivalents.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [82]
In the citing paper
“Ninety-day mortality in the permissive hypotension and usual care groups was similar (41.0% vs 43.8%).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [82]
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414
Goal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404380 · Cited by 2,028
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Trial of early, goal-directed resuscitation for septic shock.
Mouncey, P. R., Osborn, T. M., Power, G. S., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Jahan, R., Harvey, S. E., Bell, D., Bion, J. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500896 · Cited by 1,604
Vincent, J.-L., & De Backer, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,425
High versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Self-citationDopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*
De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823778ee · Cited by 389
Dünser, M. W., Mayr, A. J., Tür, A., Pajk, W., Barbara, F., Knotzer, H., Ulmer, H., & Hasibeder, W. R. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059722.94182.79 · Cited by 250
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study
Schmittinger, C. A., Torgersen, C., Luckner, G., Schröder, D. C. H., Lorenz, I., & Dünser, M. W. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2531-2 · Cited by 246
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · Chest · doi:10.1378/chest.12-1106 · Cited by 209
Effects of Norepinephrine on the Renal Vasculature in Normal and Endotoxemic Dogs
BELLOMO, R., KELLUM, J. A., WISNIEWSKI, S. R., PINSKY, M. R., & Ondulik, B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9802055 · Cited by 180
Severe Sepsis and Septic Shock
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1312359 · Cited by 143
Mean perfusion pressure deficit during the initial management of shock—an observational cohort study
Panwar, R., Lanyon, N., Davies, A. R., Bailey, M., Pilcher, D. V., & Bellomo, R. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.05.009 · Cited by 57
Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials
Heyland, D. K., Muscedere, J., Drover, J., Jiang, X., Day, A. G., & the Canadian Critical Care Trials Group (2011) · Critical Care · doi:10.1186/cc10110 · Cited by 56
Self-citationBlood Pressure Targets For Vasopressor Therapy: A Systematic Review
D’Aragon, F., Belley‐Côté, E. P., Meade, M. O., Lauzier, F., Adhikari, N. K. J., Briel, M., Lalu, M. M., Kanji, S., Asfar, P., Turgeon, A. F., et al. (2015) · Shock · doi:10.1097/shk.0000000000000348 · Cited by 52
Self-citationReliability and Validity of the Adult Alpha Functional Independence Measure Instrument in England
Hinkle, J. L., McClaran, J., Davies, J., & Ng, D. K. (2010) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3181c1fd99 · Cited by 17
Challenging the rationale of routine vasopressor therapy for management of hypotension
Weil, M. H., & Tang, W. (2009) · Critical Care · doi:10.1186/cc7976 · Cited by 7
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“In particular, this “low” MAP target is recommended over higher MAP targets based on the literature.(18,19)”
BackgroundSelf-citationSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationEuropean Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Metadata
- Authors
- for the Canadian Critical Care Trials Group., Lamontagne, F., Meade, M. O., Hébert, P. C., Asfar, P., Lauzier, F., Seely, A. J. E., Day, A. G., Mehta, S., Muscedere, J., Bagshaw, S. M., Ferguson, N. D., Cook, D. J., Kanji, S., Turgeon, A. F., Herridge, M. S., Subramanian, S., Lacroix, J., Adhikari, N. K. J., Scales, D. C., Fox-Robichaud, A., Skrobik, Y., Whitlock, R. P., Green, R. S., Koo, K. K. Y., Tanguay, T., Magder, S., & Heyland, D. K.
- Affiliations
- Université de Sherbrooke (CA)
- Université de Montréal (CA)
- Université d'Angers (FR)
- Université Laval (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- University of Alberta (CA)
- Ottawa Hospital Research Institute (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Sunnybrook Health Science Centre (CA)
- McGill University (CA)
- Dalhousie University (CA)
- Swedish Medical Center (US)
- Kingston General Hospital (CA)
- Corresponding author
- Lamontagne, François
- ORCID
- Lamontagne, François
- Meade, Maureen O.
- Hébert, Paul C.
- Asfar, Pierre
- Lauzier, François
- Seely, Andrew J.E.
- Day, Andrew G.
- Mehta, Sangeeta
- Muscedere, John
- Bagshaw, Sean M.
- Ferguson, Niall D.
- Kanji, Salmaan
- Turgeon, Alexis F.
- Herridge, Margaret S.
- Subramanian, Sanjay
- Adhikari, Neill K.J.
- Scales, Damon C.
- Skrobik, Yoanna
- Whitlock, Richard P.
- Green, Robert S.
- Koo, Karen K.Y.
- Magder, Sheldon
- Heyland, Daren K.
- Venue
- Intensive Care Medicine
- Published
- 2016-02-18
- Volume
- 42
- Issue
- 4
- Pages
- 542-550
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2287296216
- Semantic Scholar
- b6880c4b9258fd5897c4bd8350c5bb4068134e46
- Cited by
- 230
- References
- 22
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 20 · 2019: 22 · 2018: 14 · 2017: 15 · 2016: 7
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute of Circulatory and Respiratory Health (126066)
- Fonds de Recherche du Québec - Santé (CA) (27102)
- Topics
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- vasopressor therapy, vasodilatory shock, mean arterial pressure targets, hypotension, vasopressor titration, cardiac arrhythmias, in-hospital mortality, critically ill patients, older adults, trial feasibility
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Hypotension, Male, Middle Aged, Pilot Projects, Shock, Vasoconstrictor Agents, Arterial Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.